March 11 & April 8, 2026
NAE and NIIMBL invite you to join a two-part webinar series highlighting insights from the Summer 2025 edition of NAE’s The Bridge.
Self-nominate for the technology and workforce development Innovation Tank sessions at the 2026 National Meeting.
Deadline: March 16, 2026
Enhance your organization’s visibility, strengthen your NIIMBL connections, and contribute to the conversations advancing biopharmaceutical manufacturing by submitting an abstract for our National Meeting.
Deadline: February 23, 2026
Collaborate on innovative manufacturing platforms and technologies that accelerate the development and manufacture of life-saving medicines and medical countermeasures, enhance national economic security, and support response to biothreats
Help companies de-risk the adoption and implementation of new technologies and approaches for development and manufacturing
Strengthen the U.S. economy by cultivating a world-leading biopharmaceutical workforce that meets the industry’s needs through novel training and education programs
Udit Batra, President & CEO, Waters
We achieve our mission through an RFx process that aims to advance technical and workforce development projects:
Deadline: March 16, 2026 (5 pm ET)
NIIMBL is organizing a special session at this year’s National Meeting, scheduled for June 23-25, 2026. Last year’s Innovation Tank session received overwhelmingly positive feedback and engagement, and we are excited to continue the format again this year.
This Request for Information (RFI) invites interested parties to self-nominate for participation in the Innovation Tank, a special pitch targeted to find the most promising technologies that directly address issues in biopharma manufacturing.
The session will feature a “Shark Tank”-style pitch event, where up to three organizations will be invited to pitch their promising biopharmaceutical manufacturing-related technology to a panel of experts.
Each selected organization will be given 20 to 30 minutes to deliver a 5-to 7-minute pitch about your technology followed by panel question and answer. The winning technology pitch will be determined by the panel with audience poll results weighted into the decision.
Deadline: March 16, 2026 (5 pm ET).
NIIMBL is organizing a special workforce session at this year’s National Meeting, scheduled for June 23-25, 2026.
This Request for Information (RFI) invites interested and eligible parties to self-nominate for participation in a special “Shark Tank” like session at the National Meeting, with an outcome of identifying the most promising new and emerging non-degree workforce program that directly addresses the challenges of building the biopharma manufacturing pipeline.
This interactive session will kick off with a brief overview of the Impact Assessment Framework, equipping the audience with the lenses through which program impact is measured by NIIMBL. Then, up to three organizations will take the stage to pitch their most innovative and impactful workforce programs. Each organization will have 20 to 30 minutes to deliver a 5–7-minute pitch and respond to questions from a panel of experts representing industry, academia, and government.
Following the pitches, both the audience and the expert panel will vote to determine which program demonstrates the greatest potential for advancing the biopharmaceutical workforce.
NIIMBL is pleased to announce the pilot of a faculty sabbatical in industry program. The NIIMBL Faculty Fellows program provides financial support for faculty or instructional staff at universities and community colleges to pursue a sabbatical either at an industry member (Tier 1 or Tier 2) or at NIIMBL’s Headquarters (NIIMBL HQ) in Delaware to support NIIMBL-led projects.
The NIIMBL Faculty Fellows program closes December 31, 2024.
Project Call 9.1 is now closed.
NIIMBL is pleased to announce Project Call 9.1, with member- driven and industry-led priority topic areas for technical development proposals.
Technology Topics:
Workforce Development Topics
We achieve our mission through an RFx process that aims to advance technical and workforce development projects:
RFI: Technology Innovation Tank
Deadline: March 16, 2026 (5 pm ET)
NIIMBL is organizing a special session at this year’s National Meeting, scheduled for June 23-25, 2026. Last year’s Innovation Tank session received overwhelmingly positive feedback and engagement, and we are excited to continue the format again this year.
This Request for Information (RFI) invites interested parties to self-nominate for participation in the Innovation Tank, a special pitch targeted to find the most promising technologies that directly address issues in biopharma manufacturing.
The session will feature a “Shark Tank”-style pitch event, where up to three organizations will be invited to pitch their promising biopharmaceutical manufacturing-related technology to a panel of experts.
Each selected organization will be given 20 to 30 minutes to deliver a 5-to 7-minute pitch about your technology followed by panel question and answer. The winning technology pitch will be determined by the panel with audience poll results weighted into the decision.
RFI: Workforce Development Innovation Tank
Deadline: March 16, 2026 (5 pm ET).
NIIMBL is organizing a special workforce session at this year’s National Meeting, scheduled for June 23-25, 2026.
This Request for Information (RFI) invites interested and eligible parties to self-nominate for participation in a special “Shark Tank” like session at the National Meeting, with an outcome of identifying the most promising new and emerging non-degree workforce program that directly addresses the challenges of building the biopharma manufacturing pipeline.
This interactive session will kick off with a brief overview of the Impact Assessment Framework, equipping the audience with the lenses through which program impact is measured by NIIMBL. Then, up to three organizations will take the stage to pitch their most innovative and impactful workforce programs. Each organization will have 20 to 30 minutes to deliver a 5–7-minute pitch and respond to questions from a panel of experts representing industry, academia, and government.
Following the pitches, both the audience and the expert panel will vote to determine which program demonstrates the greatest potential for advancing the biopharmaceutical workforce.
RFA: Faculty Fellows
NIIMBL is pleased to announce the pilot of a faculty sabbatical in industry program. The NIIMBL Faculty Fellows program provides financial support for faculty or instructional staff at universities and community colleges to pursue a sabbatical either at an industry member (Tier 1 or Tier 2) or at NIIMBL’s Headquarters (NIIMBL HQ) in Delaware to support NIIMBL-led projects.
The NIIMBL Faculty Fellows program closes December 31, 2024.
RFP: Project Call 9.1
Project Call 9.1 is now closed.
NIIMBL is pleased to announce Project Call 9.1, with member- driven and industry-led priority topic areas for technical development proposals.
Technology Topics:
Workforce Development Topics
Our members are stakeholders from across the biopharmaceutical manufacturing ecosystem, including large and small companies, academic institutions, and nonprofits.
Members have the opportunity to collectively revolutionize current biomanufacturing platforms, processes, and educational programs and share in the benefits of these transformative solutions.
The NIIMBL ecosystem’s collaborative efforts to accelerate innovative manufacturing technologies help to:
Biopharmaceuticals are medicines and medical countermeasures that save, sustain, and improve lives. They:
Mike Kress, Sr. Vice President Development Sciences and Clinical Supply,
Merck & Co., Inc.
We offer a variety of membership options that give you the flexibility to choose your organization’s level of engagement based on technology interests and priorities.
